Tattva Limited raises £208k to develop microbial tissue engineering for construction
Published
Microbial tissue engineering is the foundation of a novel, bioengineered construction system being developed by Tattva Limited. The Crediton-based company focuses on the production of high-performance industrial materials designed to offer properties including fire-safety, insulation, and structural strength. These products are intended to provide sustainable and efficient solutions for the modern construction industry through research and experimental development on biotechnology.
This latest funding round involved an estimated investment of £208.2k. Following the transaction, the business reached an estimated post-money valuation of £1.7m. The startup was incorporated in 2024.
Financial records for the year ended 31 March 2025 show the firm operated with a team of two employees. This capital injection was finalized through a share allotment and subsequent documentation filing in June.
Contact the editorial team at [email protected]